COO
The Cooper Companies, Inc.
NMS
$67.88
+0.37
(+0.55%)
Extended · +1.88σ
Grade C
132-Day TAO Zones
21 EMA
+1 ATR
+2 ATR
−2 ATR
—
O —
H —
L —
C —
—
—
Key statistics
Mkt cap
$13.2B
P/E ttm
57.5
Fwd P/E
13.6
Beta
0.87
Day range
$67.88
52w range
$58.89 – $85.04
Avg vol
2.5M
RSI(2)
68.8
ROE
2.9%
Net mgn
5.6%
FCF mgn
10.0%
Debt/Eq
0.33
Div yld
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Next earn
2026-09-03
Matrix setup grades
Long
C
score 31 · tech 31 / 80 · support 0 / 20
above KC1 lower, +1.90 ATR from EMA21 · hammer
- · Hammer candle — long lower wick rejection
- · Aligned with strong_uptrend (strong tailwind)
Short
—
score 22 · tech 22 / 80 · support 0 / 20
KC2 upper, +1.90 ATR from EMA21 · no notable pattern
ℹ️ Stretched (KC2): stop is set a little wider to avoid a whipsaw, so the reward/risk reads a bit lower by design.
- · KC2 upper stretch — standard mean-reversion tier
- · Counter-trend short in strong_uptrend
Valuation & accounting
DCF + multiples · long-term lensIntrinsic (DCF)
$31.99
Fair-value range
$21.24 – $62.95
Margin of safety
-109%
Verdict
Overvalued
Accounting quality
Weak
- ✓ Debt/equity 0.50 (antifragile)
- ✓ Positive retained earnings
- ✓ Gross margin 66% (pricing power)
- ⚠ Debt exceeds cash
- ⚠ Quick ratio 0.87 (fragile)
- ⚠ Receivables growing faster than revenue
Price implies ~18% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
Options · swing
See more →
CALL
$70
2026-07-17
$1.95
PUT
$70
2026-07-17
$3.60
Insider activity
See more →No Form 4 filings in the last 30 days.
Earnings
See more →- Last reported
- 2026-06-04
- EPS (act / est)
- 1.21 / 1.09
- Surprise
- +10.5%
- Next report
- 2026-09-03
About
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses…